DRI Healthcare Trust Reports First Quarter 2023 Results Canada NewsWire TORONTO, May 11, 2023 – Robust royalty...
DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences Canada NewsWire TORONTO, May 10...
DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 12, 2023 Canada NewsWire TORONTO...
DRI Healthcare Trust Announces Sale of its TZIELD™ Royalty Interest to Sanofi for US$210 Million and...
DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of TZIELD™...
DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2022 Results Canada NewsWire TORONTO, March 1, 2023 –...
DRI Healthcare Trust to Host Fourth Quarter and Full Year 2022 Earnings Call and Webcast on March 2, 2023 Canada NewsWire TORONTO, Feb. 16, 2023...
DRI Healthcare Trust Announces US$95 million Private Placement of Preferred Securities and Increased...
DRI Healthcare Trust Declares Unit Distribution and Provides Update on Normal Course Issuer Bid Canada NewsWire TORONTO, Dec. 21, 2022 TORONTO...
DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of Xenpozyme® (olipudase alfa) for the Treatment of...
DRI Healthcare Trust Reports Third Quarter 2022 Results Canada NewsWire TORONTO, Nov. 7, 2022 - Transactions...
DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 8, 2022 Canada NewsWire TORONTO, Oct. 25, 2022 TORONTO, Oct. 25...
DRI Healthcare Trust Provides Update on Natpara Royalty Canada NewsWire TORONTO, Oct. 3, 2022 TORONTO, Oct. 3...
DRI Healthcare Trust Announces Acquisition of a Royalty Interest in Zejula®, Currently Approved for the...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.